Peptidylprolyl isomerase A pseudogene 44 (PPIAP44)

Peptidylprolyl isomerase A pseudogene 44 (PPIAP44) is classified as a pseudogene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they are generally not transcribed or translated into functional proteins and do not have established roles as drug targets or disease mediators. PPIAP44 is annotated in public gene databases, but there is no experimental evidence for protein product or direct biological or clinical function. PPIAP44 is explicitly labeled a pseudogene, meaning it is a DNA segment resembling a gene but usually non-functional due to mutations or lack of regulatory elements. Pseudogenes do not encode active proteins or enzymes. There is no evidence in primary scientific databases (NCBI, Ensembl, UniProt, published reviews) that PPIAP44 produces an active protein or is a valid pharmacological or therapeutic target. No publications or curated databases link PPIAP44 to diseases, drug actions, or use as a clinical biomarker. Its "parent" gene, PPIA (peptidylprolyl isomerase A, cyclophilin A), is a well-studied protein involved in key biological processes and is implicated in a variety of diseases. However, PPIAP44 itself is distinct and unstudied beyond its annotation as a pseudogene. Some pseudogenes can, in rare cases, influence gene regulation or disease as non-coding RNAs, but there are no reports or studies describing such a role for PPIAP44. There are no known aliases beyond its standardized name and gene symbol. In summary, PPIAP44 is not a functional or actionable molecular target and lacks direct biological or clinical significance in current scientific knowledge.

Other names

PPIAP44